FLGTFulgent Genetics, Inc.

Nasdaq fulgentgenetics.com


$ 20.34 $ 0.25 (1.24 %)    

Friday, 19-Apr-2024 15:59:51 EDT
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 20.36
$ 20.26
$ 0.00 x 0
$ 0.00 x 0
$ 20.08 - $ 20.34
$ 19.88 - $ 44.09
156,226
na
606.4M
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-07-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-08-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 03-13-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-22-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-20-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-17-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-neutral-on-fulgent-genetics-lowers-price-target-to-25

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Core News & Articles

Testing offers CBR families the opportunity to proactively seek additional information about their child's health

 ubs-initiates-coverage-on-fulgent-genetics-with-neutral-rating-announces-price-target-of-35

UBS analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Neutral rating and announces Price Targe...

 earnings-scheduled-for-november-3-2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...

 piper-sandler-maintains-neutral-on-fulgent-genetics-lowers-price-target-to-28

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 369 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 why-is-fulgent-genetics-stock-moving-higher-today

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

 fulgent-genetics-q2-adjusted-eps-008-beats-033-estimate-sales-6785m-beat-6268m-estimate

Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION